Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): A possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans

Pathology International

Volumn 47, Issue 7, 1997, Pages 442-448

  Koirala, Tirtha Raj ^a   Hayashi, Kazuhiko ^a   Chen, Hong Li ^a   Ino, Hideo ^a   Kariya, Naoyuki ^a   Yanai, Hiroyuki ^a   Choudhury, Chitta Ranjan ^a   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Animal model; Epstein Barr virus; Herpes virus; Human T lymphotropic virus; Malignant lymphoma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; EPSTEIN BARR VIRUS; HERPES VIRUS; LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION;

EID: 0030914825     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04522.x     Document Type: Article

References (22)

1. Hayashi K, Koirala TR, Ino H et al. Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr virus-related herpesvirus from HTLV-II transformed Cynomolgus leukocyte cell line (Si-IIA). Int. J. Cancer 1995; 63: 872-880.
2. Miyamoto K, Tomita N, Ohtsuki Y, Kitajima K. Detection of provirus in an HTLV-II producer CD8 T cell line by polymerase chain reaction combined with digoxigenin-ELISA method. Jpn. J. Cancer Res. 1990; 81: 313-316.
3. Miyamoto K, Tomita N, Hayashi K, Akagi T. Transformation of animal cells with human T-cell leukemia virus type II. Jpn. J. Cancer Res. 1990; 81: 720-722.
4. Hayashi K, Ohara N, Fujiwara K et al. Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by coculturing normal human cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA). J. Cancer Res. Clin. Oncol. 1993; 119: 137-141.
5. Ohara N, Hayashi K, Miyamoto K et al. A human T cell line with an abnormal trisomy 2 karyotype established by coculture of peripheral lymphocytes with an HTLV-II-infected simian leukocyte cell line. Acta Pathol. Jpn. 1993; 43: 237-243.
6. Hayashi K, Ohara N, Koirala TR et al. HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA). Jpn. J. Cancer Res. 1994; 85: 808-818.
7. Fleckenstein B, Desrosiers RC. Herpesvirus saimiri and Herpesvirus ateles. In: Roizman B ed. Herpesvirus, Vol. 1. Plenum Press, New York, 1982; 253-331.
8. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 1994; 145: 239-252.
9. Saemuddin AK, Albeck H, Hansen JPH. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas in Greenland Eskimos. Br. J. Cancer 1982; 46: 721-728.
10. Weiss LM, Movahed LA, Warnke R, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 320: 502-506.
11. Teramoto N, Akagi T, Yoshino T, Takahashi K, Jeon HJ. Direct detection of Epstein-Barr virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction. Jpn. J. Cancer Res. 1992; 83: 329-333.
12. Pallesen G, Hamilton-Dutoit SJ, Rowe M et al. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J. Pathol. 1991; 165: 289-299.
13. Baer R, Bankier AT, Biggin MD et al. DNA sequence and expression of the B-95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-211.
14. Hayashi K, Ohara N, Fujiwara K et al. HTLV-II-specific antisera raised in rabbits immunized with a synthetic peptide. Virchows Arch. B Cell Pathol. 1992; 63: 37-41.
15. Miller G. Epstein-Barr virus: Biology, pathogenesis, and medical aspects. In: Fields BN, Knipe DM, eds. Virology, 2nd edn. Raven Press, New York, 1990; 1921-1958.
16. Niedobitek G, Agathanggelou A, Finerty S et al. Latent Epstein-Barr-virus infection in cottontop tamarins: A possible model for Epstein-Barr virus infection in humans. Am. J. Pathol. 1994; 145: 969-978.
17. Miller G, Shope T, Coope D. Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: Tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses. J. Exp. Med. 1977; 45: 948-967.
18. Rezikyan S, Kaaya EE, Ekman M et al. B-cell lymphomagenesis in SIV-immunosuppressed Cynomolgus monkeys. Int. J. Cancer 1995; 61: 574-579.
19. Li SL, Biberfeld P, Ernberg I. DNA of lymphoma-associated herpesvirus (HVMF-1) in SIV-infected monkeys (Macaca fascicularis) shows homologies to EBNA-1, -2 and -5 genes. Int. J. Cancer 1994; 59: 287-295.
20. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. Lancet 1994; 343: 333-335.
21. Miyashita EM, Yang B, Lang KMC, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995; 80: 593-601.
22. Yao QY, Ogan P, Rowe M, Wood M, Rikinson AB. Epstein-Barr virus infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 1989; 43: 67-71.